Quantitative Imaging: Current and Future Practice in Radiology and Clinical Trials

| | Health Imaging | Artificial Intelligence

Sunday, Nov. 25, 2:00-3:30 p.m. | S404CD

Speakers share various perspectives on quantitative imaging and outline its role in the RSNA 2011-2016 Strategic Plan. Barriers to the dissemination of quantitative imaging also will be discussed.

Speaker Information:

  • Michael F. McNitt Gray, PhD, University of California, Los Angeles
  • Daniel C. Sullivan, MD, Duke University Medical Center, Durham, N.C.
  • Laurence P. Clarke, PhD, National Cancer Institute, Bethesda, Md.
  • Mitchell Dennis Schnall, MD, PhD, University of Pennsylvania, Philadelphia

 

Related Content

Commercially available AI increases breast cancer detection by nearly 20%
Clinicians want AI to show its work
New cardiac prevention paradigm explored in TRANSFORM trial using AI and CCTA
PHOTO GALLERY: Medical imaging technology at RSNA 2024
Cardiology, radiology specialists debate CCTA’s rise as a go-to imaging modality for CAD
Can large language models break language barriers in radiology reports?

Around the web

Radiology Business
The biggest obstacles facing radiology business managers in 2025

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.

Cardiovascular Business
New cardiac prevention paradigm explored in TRANSFORM trial using AI and CCTA

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.

Cardiovascular Business
Cardiology practices pay $17.7M to settle fraud allegations brought on by whistleblowers

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.